Faina Nakhlis

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Venues

Annals of surgical oncology

Breast cancer research and treatment

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Faina Nakhlis, Samuel M Niman, Naoto T Ueno, Elizabeth Troll, Sean Ryan, Eren Yeh, Laura Warren, Jennifer Bellon, Beth Harrison, Toshiaki Iwase, H T Carisa Le-Petross, Sadia Saleem, Mediget Teshome, Gary J Whitman, Wendy A Woodward, Beth Overmoyer, Sara M Tolaney, Meredith Regan, Filipa Lynce, Rachel M Layman
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer. Breast cancer research and treatment (2023)
Faina Nakhlis, Samuel M Niman, Naoto T Ueno, Elizabeth Troll, Sean Ryan, Eren Yeh, Laura Warren, Jennifer Bellon, Beth Harrison, Toshiaki Iwase, H T Carisa Le-Petross, Sadia Saleem, Mediget Teshome, Gary J Whitman, Wendy A Woodward, Beth Overmoyer, Sara M Tolaney, Meredith Regan, Filipa Lynce, Rachel M Layman
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer. Breast cancer research and treatment 204 (2) (2023)
Ana Christina Garrido-Castro, Meredith M Regan, Samuel M Niman, Faina Nakhlis, Claire Remolano, Jennifer M Rosenbluth, Caroline Block, Laura E G Warren, Jennifer R Bellon, Eren Yeh, Beth T Harrison, Elizabeth Troll, Nancy U Lin, Sara M Tolaney, Beth A Overmoyer, Filipa C Lynce
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer. NPJ breast cancer 9 (1) (2023)
Faina Nakhlis, Samuel M Niman, Naoto T Ueno, Elizabeth Troll, Sean Ryan, Eren Yeh, Laura Warren, Jennifer Bellon, Beth Harrison, Toshiaki Iwase, H T Carisa Le-Petross, Sadia Saleem, Mediget Teshome, Gary J Whitman, Wendy A Woodward, Beth Overmoyer, Sara M Tolaney, Meredith Regan, Filipa Lynce, Rachel M Layman
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer. Breast cancer research and treatment 204 (2) (2023)
Faina Nakhlis, Fisher D Katlin, Samantha C Grossmith, Ashley DiPasquale, Beth T Harrison, Stuart J Schnitt, Tari A King
Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS. Annals of surgical oncology 29 (12) (2022)
Faina Nakhlis
Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery? Annals of surgical oncology 29 (10) (2022)
Faina Nakhlis, Fisher D Katlin, Samantha C Grossmith, Ashley DiPasquale, Beth T Harrison, Stuart J Schnitt, Tari A King
ASO Visual Abstract: The Presence of Non-classic LCIS is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS. Annals of surgical oncology 29 (12) (2022)
Faina Nakhlis
ASO Visual Abstract: Inflammatory Breast Cancer-Is There a Role for De-escalation of Surgery? Annals of surgical oncology 29 (10) (2022)
Mark Fairweather, Wei Jiang, Nancy L Keating, Rachel A Freedman, Tari A King, Faina Nakhlis
Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare Registry. Breast cancer research and treatment 169 (2) (2018)

Faina Nakhlis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Faina Nakhlis